June 1, 2020
RFA-HL-20-029 "Limited Competition: Small Grant Program for NHLBI K01/K08/K23 Recipients (R03 - Clinical Trial Optional)"
National Heart, Lung, and Blood Institute (NHLBI)
The purpose of this notice is to inform potential applicants that a second application due date of July 10, 2020 for all types of non-AIDS applications has been added for the January 2021 Advisory Council Review for RFA-HL-20-029 "Limited Competition: Small Grant Program for NHLBI K01/K08/K23 Recipients (R03 - Clinical Trial Optional)". Scientific Merit Review, Advisory Council Review, Earliest Start Date and Expiration Date remain unchanged.
The following section of RFA-HL-20-029 has been updated to reflect the additional application due date for the January 2021 Advisory Council Review:
Part 1. Overview Information
Key Dates
Currently reads:
Application Due Date(s)
December 2, 2019, February 7, 2020; June 8, 2020; October 8, 2020; February 8, 2021; June 8, 2021; October, 8, 2021
Modified to read:
Application Due Date(s)
December 2, 2019, February 7, 2020; June 8, 2020; July 10, 2020; October 8, 2020; February 8, 2021; June 8, 2021; October, 8, 2021
All other aspects of the FOA remain unchanged.
Roya Kalantari, PhD
National Heart, Lung, and Blood Institute (NHLBI)
Telephone: 301-480-1989
Email: [email protected]